HMGA2 and acute lymphoblastic leukemia: These data highlighted that the let-7b-HMGA2-CDKN2A axis regulates cell proliferation of leukaemic cells and could be a possible molecular target for the treatment of infant ALL with KMT2A-AFF1 [218].